about
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, an...
Read More
6.86
-0.05
(-0.72%)
548.0K
XNAS Volume
XNAS 30 Dec, 2025 4:30 PM (EST)
Medium Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks have average quality, financial and technical momentum, indicating a mid range performer
View Similar
Embed DVM
Mimedx Grp Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..